TCL Archive Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices September 25, 1992
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts. January 20, 2006
